Meta-Analysis: Risk of Dementia Up in Type 2 Diabetes

This article originally appeared here.
Share this content:
Meta-Analysis: Risk of Dementia Up in Type 2 Diabetes
Meta-Analysis: Risk of Dementia Up in Type 2 Diabetes

FRIDAY, Dec. 18, 2015 (HealthDay News) -- The risk of dementia is increased for individuals with type 2 diabetes, and the additional risk of vascular dementia, but not nonvascular dementia, is greater in women than in men, according to a meta-analysis published online Dec. 17 in Diabetes Care.

Saion Chatterjee, from Alfred Health in Melbourne, Australia, and colleagues conducted a meta-analysis to examine the sex-specific relationship between women and men with diabetes and incident dementia. Data were included from 14 studies, with 2,310,330 individuals and 102,174 dementia case patients.

The researchers found that diabetes correlated with an increased risk of any dementia in both sexes (women: pooled relative risk [RR], 1.62; men: pooled RR, 1.58), in multiple-adjusted analyses. For vascular dementia, the diabetes-associated RRs were 2.34 in women and 1.73 in men; the corresponding RRs were 1.53 and 1.49 for nonvascular dementia. Compared with men, women with diabetes had an increased risk for the development of vascular dementia (multiple-adjusted ratio of RRs, 1.19; P < 0.001).

"Individuals with type 2 diabetes are at ~60 percent greater risk for the development of dementia compared with those without diabetes," the authors write. "For vascular dementia, but not for nonvascular dementia, the additional risk is greater in women."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »